45 studies found for:    Open Studies | "Staphylococcal Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Staphylococcal Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73
Condition: Staphylococcal Infection
Interventions: Other: Placebo;   Drug: XF-73 in 4% Klucel gel;   Drug: XF-73 in 2% Klucel gel
2 Recruiting Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition: Staphylococcal Infection
Intervention: Drug: Mupirocin calcium
3 Not yet recruiting Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection
Condition: Staphylococcal Infections
Intervention: Drug: Daptomycin
4 Unknown  A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely
Condition: Staphylococcal Infections
Intervention: Drug: teicoplanin
5 Unknown  Preoperative Nasal Swabs From Pediatric Patients
Condition: Staphylococcal Infections
Intervention: Procedure: Nose swab
6 Unknown  Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant
Condition: Staphylococcal Infections
Intervention:
7 Recruiting Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci
Conditions: Lock Solution;   Catheter Related Blood Stream Infections;   Central Venous Catheter Infection;   Intravenous Drug Delivery Systems;   Coagulase-negative Staphylococci Infection
Interventions: Drug: Ethanol 40% + Enoxaparine 400UI/ml;   Drug: Vancomycine 5 mg/ml + Héparine 2500UI/ml
8 Recruiting Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial
Conditions: Staph Aureus Colonization;   Staph Aureus Infection
Interventions: Drug: Mupirocin and Chlorhexidine;   Drug: Placebo ointment and placebo cloths
9 Recruiting Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
Condition: Staph Aureus Methicillin Resistant Bacteremia
Interventions: Drug: Fosfomycin 2gr/6h iv;   Drug: Daptomycin  10mg/kg/24h iv
10 Recruiting Impact of Mupirocin Decolonization on the Nasal Microbiome
Condition: Nasal Colonization With Staph Aureus
Intervention:
11 Recruiting Biotherapy for MRSA Enterocolitis
Condition: Methicillin-Resistant Staphylococcus Aureus
Intervention: Other: Fecal microbiota transplantation
12 Recruiting Retapamulin for Reducing MRSA Nasal Carriage
Condition: Methicillin-Resistant Staphylococcus Aureus
Interventions: Drug: Retapamulin;   Drug: Placebo
13 Recruiting Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients
Condition: MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Interventions: Drug: Vancomycin continuous infusion;   Drug: Vancomycin intermittent dosing interval
14 Unknown  Community-Acquired Methicillin Resistant Staphylococcus Aureus Colonization in Pregnant Women and Infections in Newborns
Condition: Staphylococcus Aureus Infection
Intervention: Other: CA-MRSA Decolonization
15 Unknown  Risk Factors for Early Infant Colonization With Methicillin-Resistant Staphylococcus Aureus
Condition: Methicillin-resistant Staphylococcus Aureus
Intervention:
16 Unknown  Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired Skin and Soft Tissue Abscess Undergoing Incision and Drainage
Conditions: Skin and Soft Tissue Abscess;   Methicillin-resistant Staphylococcus Aureus (MRSA) Infection
Intervention: Drug: Oral Clindamycin
17 Recruiting Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
Condition: Cystic Fibrosis
Interventions: Drug: Inhaled Vancomycin;   Drug: Placebo (Sterile Water);   Drug: Rifampin;   Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX);   Drug: Doxycycline;   Drug: Mupirocin Nasal Ointment;   Drug: 4% chlorhexidine gluconate liquid skin cleanser
18 Unknown  Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community
Conditions: ESBL Infection;   Methicillin-Resistant Staphylococcus Aureus
Intervention:
19 Unknown  Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients in Brazil
Condition: Methicillin Resistant Staphylococcus Aureus
Intervention:
20 Unknown  Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
Condition: Methicillin-Resistant Staphylococcus Aureus
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years